Copyright
©The Author(s) 2024.
World J Diabetes. Sep 15, 2024; 15(9): 1889-1902
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1889
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1889
Table 2 Anthropometric and clinical characteristics distribution of study participants at Bishoftu General Hospital, central Ethiopia, from June 15 to August 12, 2022, n (%)
| Variables | Categories | T2DM patients | Healthy control | P value | |
| BMI (kg/m2) | Median (IQR) | 23.2 (20.6-25.3) | 20.3(19.1-22.03) | < 0.001 | |
| WC (cm) | Median (IQR) | 90 (87-97) | 89 (86-92) | 0.017 | |
| WHR | Median (IQR) | 0.91 (0.86-0.98) | 0.87 (0.83-0.92) | < 0.001 | |
| SBP (mmHg) | Median (IQR) | 141 (133-150) | 131 (126-135) | < 0.001 | |
| DBP (mmHg) | Median (IQR) | 101 (94.0-109.0) | 90 (87.0-92.0) | < 0.001 | |
| FBG level (mg/dL) | Median (IQR) | 131.2 (114.7-150) | - | - | |
| Duration of DM illness (years) | Median (IQR) | 6.0 (3.0-10.0) | - | - | |
| Presence of microvascular complications at least one type | Poor glycemic DM (87) | Yes | 45 (51.7) | - | - |
| No | 42 (48.3) | ||||
| Good glycemic DM (87) | Yes | 0 (0) | - | ||
| No | 87 (100) | ||||
| Current oral hypoglycemic therapy used by DM patients | Glibenclamide | 41 (23.60) | - | - | |
| Metformin | 89 (51.1) | - | |||
| Metformin + Glibenclamide | 44 (25.3) | - | |||
- Citation: Regassa DA, Berihun GA, Habtu BF, Haile WB, Nagaash RS, Kiya GT. Platelet indices as predictors of poor glucoregulation in type 2 diabetes mellitus adults at Bishoftu General Hospital, Ethiopia. World J Diabetes 2024; 15(9): 1889-1902
- URL: https://www.wjgnet.com/1948-9358/full/v15/i9/1889.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i9.1889